Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupuncture needles take on Cancer-Related anxiety

NCT ID NCT07183813

Symptom relief Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether acupuncture can reduce anxiety and depression in women with breast cancer. Researchers will compare real electroacupuncture to a sham version in 360 participants. The goal is to see if this needle-based therapy improves emotional well-being without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
acupuncture (electroacupuncture)
What this could lead to
If it works, this could offer a drug-free option to help breast cancer patients manage anxiety and depression.
What could go wrong
This is an early-stage trial with no phase, so results are uncertain. The sham control group may also show improvement, making it hard to prove real benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female, aged 18 to 70 years old; 2. Meeting the diagnostic criteria for breast cancer and at TMN I-III; 3. Having completed specialized active treatment for at least one month; 4. With an ECOG score of 0-2; 5. Mild to moderate anxiety and/or depression; 6. Voluntarily joining this study and signing the informed consent form. Exclusion Criteria: 1. Starting to take or change the regimen of anti-anxiety and/or -depression disorder medication within one month before enrolment; 2. Received psychological intervention or physical therapy one month before enrolment or planning to use in the next 5 months; 3. With diagnosis of anxiety and/or depression disorder prior to the diagnosis of breast cancer; 4. Patients with suicidal tendencies, bipolar disorder and psychotic symptoms; 5. Patients with severe anxiety and/or depression； 6. Patients received acupuncture treatment within one month before enrolment; 7. Participating in other clinical studies on the treatment of anxiety and/or depression; 8. Combined with severe underlying diseases; 9. Patients with severe skin ulcers; 10. Pregnant or lactating patients; 11. Poor compliance.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupuncture are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm mixed anxiety and depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acupuncture Anxiety depression Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.